Cargando…

Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231

Detalles Bibliográficos
Autores principales: Weil, E. Jennifer, Fufaa, Gudeta, Jones, Lois I., Lovato, Tracy, Lemley, Kevin V., Hanson, Robert L., Knowler, William C., Bennett, Peter H., Yee, Berne, Myers, Bryan D., Nelson, Robert G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828456/
https://www.ncbi.nlm.nih.gov/pubmed/29305527
http://dx.doi.org/10.2337/db18-er03a
_version_ 1783302650357350400
author Weil, E. Jennifer
Fufaa, Gudeta
Jones, Lois I.
Lovato, Tracy
Lemley, Kevin V.
Hanson, Robert L.
Knowler, William C.
Bennett, Peter H.
Yee, Berne
Myers, Bryan D.
Nelson, Robert G.
author_facet Weil, E. Jennifer
Fufaa, Gudeta
Jones, Lois I.
Lovato, Tracy
Lemley, Kevin V.
Hanson, Robert L.
Knowler, William C.
Bennett, Peter H.
Yee, Berne
Myers, Bryan D.
Nelson, Robert G.
author_sort Weil, E. Jennifer
collection PubMed
description
format Online
Article
Text
id pubmed-5828456
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-58284562018-03-01 Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231 Weil, E. Jennifer Fufaa, Gudeta Jones, Lois I. Lovato, Tracy Lemley, Kevin V. Hanson, Robert L. Knowler, William C. Bennett, Peter H. Yee, Berne Myers, Bryan D. Nelson, Robert G. Diabetes Errata American Diabetes Association 2018-03 2018-01-05 /pmc/articles/PMC5828456/ /pubmed/29305527 http://dx.doi.org/10.2337/db18-er03a Text en © 2018 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
spellingShingle Errata
Weil, E. Jennifer
Fufaa, Gudeta
Jones, Lois I.
Lovato, Tracy
Lemley, Kevin V.
Hanson, Robert L.
Knowler, William C.
Bennett, Peter H.
Yee, Berne
Myers, Bryan D.
Nelson, Robert G.
Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
title Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
title_full Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
title_fullStr Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
title_full_unstemmed Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
title_short Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
title_sort erratum. effect of losartan on prevention and progression of early diabetic nephropathy in american indians with type 2 diabetes. diabetes 2013;62:3224–3231
topic Errata
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828456/
https://www.ncbi.nlm.nih.gov/pubmed/29305527
http://dx.doi.org/10.2337/db18-er03a
work_keys_str_mv AT weilejennifer erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231
AT fufaagudeta erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231
AT jonesloisi erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231
AT lovatotracy erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231
AT lemleykevinv erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231
AT hansonrobertl erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231
AT knowlerwilliamc erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231
AT bennettpeterh erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231
AT yeeberne erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231
AT myersbryand erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231
AT nelsonrobertg erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231